期刊
FEBS LETTERS
卷 581, 期 28, 页码 5440-5444出版社
WILEY
DOI: 10.1016/j.febslet.2007.10.046
关键词
breast cancer; chemotherapy resistance; tumor development; tumor suppressor; apoptosis
资金
- NCI NIH HHS [R01 CA076406, CA 76406, R01 CA101992, CA 112102, CA 101992, R01 CA076406-05S1, R01 CA112102] Funding Source: Medline
Expression of p53-target gene EI24/PIG8 is lost in invasive breast cancers, suggesting that EI24/PIG8 is a tumor suppressor that prevents tumor spreading, and partially mediates p53-attributed tumor suppressor activity. EI24/PIG8 also has pro-apoptotic activity indicating that loss of EI24/PIG8 may modulate sensitivity to chemotherapy. Here it is demonstrated that suppression of EI24/PIG8 in fibroblasts and breast cancer cells significantly inhibits the apoptotic response to etoposide treatment. These findings suggest that loss of EI24/PIG8 contributes significantly to resistance of cells to chemotherapeutic agents that function through p53, and identify the EI24/PIG8 status as a potentially new prognostic marker of chemotherapy responsiveness. (c) 2007 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据